{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02947191",
      "OrgStudyIdInfo": {
        "OrgStudyId": "CAS-XDA-NSP/IGDB"
      },
      "Organization": {
        "OrgFullName": "Chinese Academy of Sciences",
        "OrgClass": "OTHER_GOV"
      },
      "BriefTitle": "Collagen Membrane Combined With HUC-MSCs Transplantation in Patients With Nasal Septum Perforation",
      "OfficialTitle": "The Safety and Efficacy Assessment of Collagen Membrane Combined With Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Patients With Nasal Septum Perforation"
    },
    "StatusModule": {
      "StatusVerifiedDate": "October 2016",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Active, not recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "November 2016"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 2021",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2021",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "October 25, 2016",
      "StudyFirstSubmitQCDate": "October 25, 2016",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "October 27, 2016",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "December 31, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "January 5, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Jianwu Dai",
        "ResponsiblePartyInvestigatorTitle": "Principal Investigator of Regenerative Medicine Laboratory, Institute of Genetics and Developmental Biology, CAS",
        "ResponsiblePartyInvestigatorAffiliation": "Chinese Academy of Sciences"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Chinese Academy of Sciences",
        "LeadSponsorClass": "OTHER_GOV"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {},
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study is to assess the safety and efficacy of collagen membrane combined with human clinical grade umbilical cord mesenchymal stem cells(HUC-MSCs) transplantation in patients with chronic nasal septum perforation."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Chronic Nasal Septum Perforation"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "12",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Collagen membrane + HUC-MSCs",
            "ArmGroupType": "Experimental",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Collagen membrane + HUC-MSCs"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Collagen membrane + HUC-MSCs",
            "InterventionDescription": "After separating bilateral nasal septum mucosas via septum reconstruction incision under endoscopy, the clinical grade HUC-MSCs combined with collagen membrane will be transplanted between the bilateral nasal septum mucosas and fixed. The patients will be treated with antibiotics for 1 week, and with naristillae menthae compositae, mucus promoting agent and other drugs for improving microcirculation for 1 month.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Collagen membrane + HUC-MSCs"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "The change of integrity of nasal septum assessed by endoscopic examination",
            "PrimaryOutcomeTimeFrame": "baseline, 1,2,3,4,8,12 weeks after surgery"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "The change of nasal mucosal physiology assessed by olfactory test",
            "SecondaryOutcomeTimeFrame": "baseline, 12 weeks after surgery"
          },
          {
            "SecondaryOutcomeMeasure": "The change of nasal mucosal physiology assessed by nasal mucociliary clearance time (MCT)",
            "SecondaryOutcomeTimeFrame": "baseline, 12 weeks after surgery"
          },
          {
            "SecondaryOutcomeMeasure": "The change of nasal airway resistance assessed by rhinomanometry",
            "SecondaryOutcomeTimeFrame": "baseline, 12 weeks after surgery"
          },
          {
            "SecondaryOutcomeMeasure": "The change of nasal obstruction assessed by acoustic rhinometry",
            "SecondaryOutcomeTimeFrame": "baseline, 12 weeks after surgery"
          },
          {
            "SecondaryOutcomeMeasure": "The change of nasal obstructive symptom assessed by visual analogue scale (VAS)",
            "SecondaryOutcomeTimeFrame": "baseline, 12 weeks after surgery"
          },
          {
            "SecondaryOutcomeMeasure": "The change of nasal symptom severity assessed by total nasal symptom score (TNSS)",
            "SecondaryOutcomeTimeFrame": "baseline, 12 weeks after surgery"
          },
          {
            "SecondaryOutcomeMeasure": "Change from baseline in computed tomography (CT)",
            "SecondaryOutcomeTimeFrame": "baseline, 12 weeks after surgery"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPatients with nasal septum perforation area less than 1cmÂ², and requires minimally-invasive treatment.\nMale or female, 18-45 years old.\nAbility and willingness to regular visit to hospital and follow up during the protocol Procedures.\n\nExclusion Criteria:\n\nCystic fibrosis, immotile cilia syndrome and other genetic diseases.\nSyphilis, leprosy, tuberculosis and other specific infections.\nSevere Sinusitis.\nAutoimmune diseases or long term treatment with corticosteroids.\nAlzheimer's disease.\nSystemic diseases (e.g.,hypertension, diabetes and so on).\nPrevious history of nasal cancer or after receiving radiotherapy.\nDrug abuse.\nHistory of mental illness.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "45 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Jianwu Dai, Ph.D",
            "OverallOfficialAffiliation": "Chinese Academy of Sciences",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School",
            "LocationCity": "Nanjing",
            "LocationState": "Jiangsu",
            "LocationZip": "210008",
            "LocationCountry": "China"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000061270",
            "ConditionMeshTerm": "Nasal Septal Perforation"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000009668",
            "ConditionAncestorTerm": "Nose Diseases"
          },
          {
            "ConditionAncestorId": "D000012140",
            "ConditionAncestorTerm": "Respiratory Tract Diseases"
          },
          {
            "ConditionAncestorId": "D000010038",
            "ConditionAncestorTerm": "Otorhinolaryngologic Diseases"
          },
          {
            "ConditionAncestorId": "D000014947",
            "ConditionAncestorTerm": "Wounds and Injuries"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M28957",
            "ConditionBrowseLeafName": "Nasal Septal Perforation",
            "ConditionBrowseLeafAsFound": "Nasal Septum Perforation",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M11756",
            "ConditionBrowseLeafName": "Nose Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14129",
            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M12113",
            "ConditionBrowseLeafName": "Otorhinolaryngologic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16837",
            "ConditionBrowseLeafName": "Wounds and Injuries",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC08",
            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC09",
            "ConditionBrowseBranchName": "Ear, Nose, and Throat Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC26",
            "ConditionBrowseBranchName": "Wounds and Injuries"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M3374",
            "InterventionBrowseLeafName": "Anti-Bacterial Agents",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M3376",
            "InterventionBrowseLeafName": "Antibiotics, Antitubercular",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "Infe",
            "InterventionBrowseBranchName": "Anti-Infective Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}